RADY-GU-SAYKIN-TLC; Older breast cancer patients: Risk for cognitive decline

Cognitive Changes in Older Women Post Breast Cancer Treatment

Recruiting
60 years - 100 years
Female
Phase N/A
1 Location

Brief description of study.

We are looking for healthy women (who have never had cancer) to participate in a study of at Indiana University School of Medicine. We are working to better understand cognitive changes after breast cancer treatment.

Detailed description of study

The purpose of this study is to evaluate the impact of systemic therapy on cognitive functioning in older breast cancer patients.

Participants will be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: healthy,breast cancer,cancer,oncology
  • Age: 60 years - 100 years
  • Gender: Female

Inclusion Criteria
In the judgment of the consenting professional, able to communicate well enough in English through verbal and written communication to complete the study assessments and provide informed consent
If currently taking psychoactive medications (including, but not limited to anticonvulsants, antidepressants, and anxiolytics), dose must have been stable at least two months prior to enrollment.
Exclusion Criteria
Participant report of a history of formal diagnosis of neurodegenerative disorder(s) that affect cognition (i.e. Alzheimer?s disease, Parkinson?s disease, multiple sclerosis, dementia, seizure disorder, etc.)
Participant report of a history of stroke or moderate to severe head trauma (loss of consciousness > 60 min or with evidence of structural brain changes on imaging)
Major depressive disorder (untreated or poorly treated), history of bipolar disorder, schizophrenia or other psychotic disorder, or substance abuse disorder (self-reported and/or stated in medical record)
Participant report of a history of prior breast or other cancer with the exception of non-melanoma skin cancer
An exception for cases only: Women who completed treatment for a previous cancer at least five years ago and have not undergone any chemotherapy or hormonal therapy. This previous cancer cannot be breast cancer.
Participant report of previous or current chemotherapy or hormonal therapy use
Participant use of methotrexate (Amethopterin, Rhematrex, Trexall) or rituximab (Rituxan) for rheumatoid arthritis, psoriasis or Crohn?s disease, or cyclophosphamide (Cytoxan, Neosar) for lupus
Two different primaries in the same or opposite breast
Visual, auditory, or other impairment that would preclude ability to complete interviews or neuropsychological testing, such as women with history of significant macular degeneration or being unable to correct hearing with hearing aides
Non-English speaking
To participate in the optional neuroimaging portion of the study:
Participant cannot be claustrophobic
Participant cannot have a pacemaker, aneurysm clip or other implants that are not MRI safe
Participant cannot have any type of implanted electrical device

Updated on 19 Feb 2024. Study ID: 1602851718

This study investigates how systemic therapy affects cognitive functioning in older women who have undergone breast cancer treatment. Cognitive functioning refers to mental processes like thinking, learning, memory, and problem-solving. Researchers aim to understand if and how these treatments impact these abilities.

Participants in this study will undergo various assessments to evaluate their cognitive functions. These assessments may include interviews and neuropsychological tests to measure different aspects of cognitive health. Participants may also choose to take part in optional neuroimaging studies, which involve taking pictures of the brain to look for changes.

  • Who can participate: Healthy women aged 60 and above who have never had cancer, are English-speaking, and can communicate well enough to complete study assessments. Participants must not have a history of neurodegenerative disorders, major depressive disorder, or other severe mental health conditions.
  • Study details: Participants will be involved in cognitive assessments, which may include interviews and tests to measure mental abilities. Some participants may also choose to participate in neuroimaging studies, which are scans that take pictures of the brain.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here